Karyopharm Therapeutics Inc. ( KPTI) - Key Metrics
KPTI Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $1.16 | -$2.32 | -$0.86 | -$0.86 |
| 2026Q1 | $1.59 | -$1.02 | -$1.03 | -$1.03 |
| 2025Q4 | $1.90 | -$5.69 | -$0.66 | -$0.66 |
| 2025Q3 | $5.08 | -$3.82 | -$0.68 | -$0.68 |
| 2025Q2 | $4.40 | -$4.32 | -$2.17 | -$2.17 |
KPTI Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -1.05 |
| 2026Q1 | 0% | -1.00 |
| 2025Q4 | 0% | -0.32 |
| 2025Q3 | 0% | -0.43 |
| 2025Q2 | 0% | -0.25 |
KPTI
Price: $1.93
52 week price:
Earnings Per Share: -14.33 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.7 million
Ebitda: -30.9 millionMarket Capitalization: 45.8 million